Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70

Journal of Immunology

Volumn 191, Issue 4, 2013, Pages 1976-1983

  Pen, Joeri J ^a   De Keersmaecker, Brenda ^a   Maenhout, Sarah K ^a   Van Nuffel, An M T ^a   Heirman, Carlo ^a   Corthals, Jurgen ^a   Escors, David ^b   Bonehill, Aude ^a   Thielemans, Kris ^a   Breckpot, Karine ^a   Aerts, Joeri L ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b Atención Primaria Y Promoción de La Salud   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD40 LIGAND; CD70 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; MESSENGER RNA; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ELECTROPORATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL;

ANTIGENS, CD70; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; ELECTROPORATION; HUMANS; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; MAP KINASE KINASE 1; MONOCYTES; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TOLL-LIKE RECEPTOR 4;

EID: 84881420246     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201008     Document Type: Article

References (76)

1. Bonertz, A., J. Weitz, D. H. Pietsch, N. N. Rahbari, C. Schlude, Y. Ge, S. Juenger, I. Vlodavsky, K. Khazaie, D. Jaeger, et al. 2009. Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma. J. Clin. Invest. 119: 3311-3321.
2. Correll, A., A. Tuettenberg, C. Becker, and H. Jonuleit. 2010. Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cellbased vaccination. Exp. Dermatol. 19: e213-e221.
3. Jandus, C., G. Bioley, D. Dojcinovic, L. Derré, L. Baitsch, S. Wieckowski, N. Rufer, W. W. Kwok, J. M. Tiercy, I. F. Luescher, et al. 2009. Tumor antigenspecific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts. Cancer Res. 69: 8085-8093.
4. Campbell, D. J., and M. A. Koch. 2011. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 11: 119-130.
5. Rudensky, A. Y. 2011. Regulatory T cells and Foxp3. Immunol. Rev. 241: 260-268.
6. Sakaguchi, S., M. Miyara, C. M. Costantino, and D. A. Hafler. 2010. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10: 490-500.
7. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787.
8. Wing, K., and S. Sakaguchi. 2010. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11: 7-13.
9. Hall, B. M., N. D. Verma, G. T. Tran, and S. J. Hodgkinson. 2011. Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells. Curr. Opin. Immunol. 23: 641-647.
10. Nishikawa, H., and S. Sakaguchi. 2010. Regulatory T cells in tumor immunity. Int. J. Cancer 127: 759-767.
11. Wilke, C. M., K. Wu, E. Zhao, G. Wang, and W. Zou. 2010. Prognostic significance of regulatory T cells in tumor. Int. J. Cancer 127: 748-758.
12. Carreras, J., A. Lopez-Guillermo, B. C. Fox, L. Colomo, A. Martinez, G. Roncador, E. Montserrat, E. Campo, and A. H. Banham. 2006. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 108: 2957-2964.
13. Salama, P., M. Phillips, F. Grieu, M. Morris, N. Zeps, D. Joseph, C. Platell, and B. Iacopetta. 2009. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J. Clin. Oncol. 27: 186-192.
14. Assis, M. C., A. H. Campos, J. S. Oliveira, F. A. Soares, J. M. Silva, P. B. Silva, A. D. Penna, E. M. Souza, and O. C. Baiocchi. 2012. Increased expression of CD4+CD25 +FOXP3+ regulatory T cells correlates with Epstein-Barr virus and has no impact on survival in patients with classical Hodgkin lymphoma in Brazil. Med. Oncol. 29: 3614-3619.
15. Carreras, J., A. Lopez-Guillermo, G. Roncador, N. Villamor, L. Colomo, A. Martinez, R. Hamoudi, W. J. Howat, E. Montserrat, and E. Campo. 2009. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J. Clin. Oncol. 27: 1470-1476.
16. Suzuki, H., H. Onishi, T. Morisaki, M. Tanaka, and M. Katano. 2013. Intratumoral FOXP3+VEGFR2+ regulatory T cells are predictive markers for recurrence and survival in patients with colorectal cancer. Clin. Immunol. 146: 26-33.
17. West, N. R., S. E. Kost, S. D. Martin, K. Milne, R. J. Deleeuw, B. H. Nelson, and P. H. Watson. 2013. Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer. Br. J. Cancer 108: 155-162.
18. Klages, K., C. T. Mayer, K. Lahl, C. Loddenkemper, M. W. Teng, S. F. Ngiow, M. J. Smyth, A. Hamann, J. Huehn, and T. Sparwasser. 2010. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma. Cancer Res. 70: 7788-7799.
19. Chen, W. 2006. Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance. Front. Biosci. 11: 1360-1370.
20. Ring, S., S. Karakhanova, T. Johnson, A. H. Enk, and K. Mahnke. 2010. Gap junctions between regulatory T cells and dendritic cells prevent sensitization of CD8(+) T cells. J. Allergy Clin. Immunol. 125: 237-246.e231-237.
21. Schildknecht, A., S. Brauer, C. Brenner, K. Lahl, H. Schild, T. Sparwasser, H. C. Probst, and M. van den Broek. 2010. FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells. Proc. Natl. Acad. Sci. USA 107: 199-203.
22. Andrews, D. M., E. Maraskovsky, and M. J. Smyth. 2008. Cancer vaccines for established cancer: how to make them better? Immunol. Rev. 222: 242-255.
23. Song, S., K. Zhang, H. You, J. Wang, Z. Wang, C. Yan, and F. Liu. 2010. Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell/regulatory T cells in tumour. Clin. Exp. Immunol. 162: 75-83.
24. Song, X. T., K. Evel-Kabler, L. Shen, L. Rollins, X. F. Huang, and S. Y. Chen. 2008. A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression. Nat. Med. 14: 258-265.
25. Warger, T., P. Osterloh, G. Rechtsteiner, M. Fassbender, V. Heib, B. Schmid, E. Schmitt, H. Schild, and M. P. Radsak. 2006. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. Blood 108: 544-550.
26. Yang, Y., C. T. Huang, X. Huang, and D. M. Pardoll. 2004. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat. Immunol. 5: 508-515.
27. Banerjee, D. K., M. V. Dhodapkar, E. Matayeva, R. M. Steinman, and K. M. Dhodapkar. 2006. Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 108: 2655-2661.
28. Belkaid, Y., and G. Oldenhove. 2008. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 29: 362-371.
29. Jonuleit, H., E. Schmitt, K. Steinbrink, and A. H. Enk. 2001. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22: 394-400.
30. Yamazaki, S., A. J. Bonito, R. Spisek, M. Dhodapkar, K. Inaba, and R. M. Steinman. 2007. Dendritic cells are specialized accessory cells along with TGF-for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors. Blood 110: 4293-4302.
31. Bayry, J., F. Triebel, S. V. Kaveri, and D. F. Tough. 2007. Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells. J. Immunol. 178: 4184-4193.
32. Shevach, E. M. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.
33. Cederbom, L., H. Hall, and F. Ivars. 2000. CD4+CD25+ regulatory T cells downregulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30: 1538-1543.
34. Misra, N., J. Bayry, S. Lacroix-Desmazes, M. D. Kazatchkine, and S. V. Kaveri. 2004. Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172: 4676-4680.
35. Qureshi, O. S., Y. Zheng, K. Nakamura, K. Attridge, C. Manzotti, E. M. Schmidt, J. Baker, L. E. Jeffery, S. Kaur, Z. Briggs, et al. 2011. Transendocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332: 600-603.
36. Berger, T. G., E. Strasser, R. Smith, C. Carste, B. Schuler-Thurner, E. Kaempgen, and G. Schuler. 2005. Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells. J. Immunol. Methods 298: 61-72.
37. Tuyaerts, S., S. M. Noppe, J. Corthals, K. Breckpot, C. Heirman, C. De Greef, I. Van Riet, and K. Thielemans. 2002. Generation of large numbers of dendritic cells in a closed system using Cell Factories. J. Immunol. Methods 264: 135-151.
38. Escors, D., L. Lopes, R. Lin, J. Hiscott, S. Akira, R. J. Davis, and M. K. Collins. 2008. Targeting dendritic cell signaling to regulate the response to immunization. Blood 111: 3050-3061.
39. Bonehill, A., S. Tuyaerts, A. M. Van Nuffel, C. Heirman, T. J. Bos, K. Fostier, B. Neyns, and K. Thielemans. 2008. Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA. Mol. Ther. 16: 1170-1180.
40. Bonehill, A., C. Heirman, S. Tuyaerts, A. Michiels, K. Breckpot, F. Brasseur, Y. Zhang, P. Van Der Bruggen, and K. Thielemans. 2004. Messenger RNAelectroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules. J. Immunol. 172: 6649-6657.
41. Jonuleit, H., U. Kühn, G. Müller, K. Steinbrink, L. Paragnik, E. Schmitt, J. Knop, and A. H. Enk. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serumfree conditions. Eur. J. Immunol. 27: 3135-3142.
42. Ahmadzadeh, M., and S. A. Rosenberg. 2006. IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood 107: 2409-2414.
43. Arce, F., K. Breckpot, H. Stephenson, K. Karwacz, M. R. Ehrenstein, M. Collins, and D. Escors. 2011. Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis. Arthritis Rheum. 63: 84-95.
44. Fallarino, F., U. Grohmann, K. W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, M. L. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4: 1206-1212.
45. Kobie, J. J., P. R. Shah, L. Yang, J. A. Rebhahn, D. J. Fowell, and T. R. Mosmann. 2006. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J. Immunol. 177: 6780-6786.
46. de la Rosa, M., S. Rutz, H. Dorninger, and A. Scheffold. 2004. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34: 2480-2488.
47. Sakaguchi, S., K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi. 2009. Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21: 1105-1111.
48. Hirahara, K., L. Liu, R. A. Clark, K. Yamanaka, R. C. Fuhlbrigge, and T. S. Kupper. 2006. The majority of human peripheral blood CD4+CD25high-Foxp3+ regulatory T cells bear functional skin-homing receptors. J. Immunol. 177: 4488-4494.
49. Mold, J. E., J. Michaëlsson, T. D. Burt, M. O. Muench, K. P. Beckerman, M. P. Busch, T. H. Lee, D. F. Nixon, and J. M. McCune. 2008. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322: 1562-1565.
50. Strauss, L., C. Bergmann, and T. L. Whiteside. 2009. Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis. J. Immunol. 182: 1469-1480.
51. Dasgupta, A., M. Mahapatra, and R. Saxena. 2013. Flow cytometric immunophenotyping of regulatory T cells in chronic lymphocytic leukemia: comparative assessment of various markers and use of novel antibody panel with CD127 as alternative to transcription factor FoxP3. Leuk Lymphoma. 54: 778-789.
52. Kubo, T., R. D. Hatton, J. Oliver, X. Liu, C. O. Elson, and C. T. Weaver. 2004. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J. Immunol. 173: 7249-7258.
53. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4 +CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
54. Croft, M. 2010. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu. Rev. Immunol. 28: 57-78.
55. Ramirez-Montagut, T., A. Chow, D. Hirschhorn-Cymerman, T. H. Terwey, A. A. Kochman, S. Lu, R. C. Miles, S. Sakaguchi, A. N. Houghton, and M. R. van den Brink. 2006. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity. J. Immunol. 176: 6434-6442.
56. Stephens, G. L., R. S. McHugh, M. J. Whitters, D. A. Young, D. Luxenberg, B. M. Carreno, M. Collins, and E. M. Shevach. 2004. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J. Immunol. 173: 5008-5020.
57. Roberts, D. J., N. A. Franklin, L. M. Kingeter, H. Yagita, A. L. Tutt, M. J. Glennie, and T. N. Bullock. 2010. Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cells. J. Immunother. 33: 769-779.
58. Hori, S. 2011. Regulatory T cell plasticity: beyond the controversies. Trends Immunol. 32: 295-300.
59. Hori, S. 2010. Developmental plasticity of Foxp3+ regulatory T cells. Curr. Opin. Immunol. 22: 575-582.
60. Rubtsov, Y. P., R. E. Niec, S. Josefowicz, L. Li, J. Darce, D. Mathis, C. Benoist, and A. Y. Rudensky. 2010. Stability of the regulatory T cell lineage in vivo. Science 329: 1667-1671.
61. Wei, G., L. Wei, J. Zhu, C. Zang, J. Hu-Li, Z. Yao, K. Cui, Y. Kanno, T. Y. Roh, W. T. Watford, et al. 2009. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30: 155-167.
62. Zhou, L., J. E. Lopes, M. M. Chong, I. I. Ivanov, R. Min, G. D. Victora, Y. Shen, J. Du, Y. P. Rubtsov, A. Y. Rudensky, et al. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453: 236-240.
63. Koch, M. A., G. Tucker-Heard, N. R. Perdue, J. R. Killebrew, K. B. Urdahl, and D. J. Campbell. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10: 595-602.
64. McClymont, S. A., A. L. Putnam, M. R. Lee, J. H. Esensten, W. Liu, M. A. Hulme, U. Hoffmüller, U. Baron, S. Olek, J. A. Bluestone, and T. M. Brusko. 2011. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 186: 3918-3926.
65. Oldenhove, G., N. Bouladoux, E. A. Wohlfert, J. A. Hall, D. Chou, L. Dos Santos, S. O'Brien, R. Blank, E. Lamb, S. Natarajan, et al. 2009. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31: 772-786.
66. Koch, M. A., K. R. Thomas, N. R. Perdue, K. S. Smigiel, S. Srivastava, and D. J. Campbell. 2012. T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor β2. Immunity 37: 501-510.
67. Lazarevic, V., and L. H. Glimcher. 2011. T-bet in disease. Nat. Immunol. 12: 597-606.
68. Duhen, T., R. Duhen, A. Lanzavecchia, F. Sallusto, and D. J. Campbell. 2012. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 119: 4430-4440.
69. Ahmadzadeh, M., P. A. Antony, and S. A. Rosenberg. 2007. IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigenspecific CD8 T cells. J. Immunother. 30: 294-302.
70. Keller, A. M., A. Schildknecht, Y. Xiao, M. van den Broek, and J. Borst. 2008. Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity. Immunity 29: 934-946.
71. Denoeud, J., and M. Moser. 2011. Role of CD27/CD70 pathway of activation in immunity and tolerance. J. Leukoc. Biol. 89: 195-203.
72. Nolte, M. A., R. W. van Olffen, K. P. van Gisbergen, and R. A. van Lier. 2009. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol. Rev. 229: 216-231.
73. van Oosterwijk, M. F., H. Juwana, R. Arens, K. Tesselaar, M. H. van Oers, E. Eldering, and R. A. van Lier. 2007. CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development. Int. Immunol. 19: 713-718.
74. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6: 1219-1227.
75. Zou, T., A. J. Caton, G. A. Koretzky, and T. Kambayashi. 2010. Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions. J. Immunol. 185: 2790-2799.
76. Wilgenhof, S., A. M. Van Nuffel, J. Corthals, C. Heirman, S. Tuyaerts, D. Benteyn, A. De Coninck, I. Van Riet, G. Verfaillie, J. Vandeloo, et al. 2011. Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma. J. Immunother. 34: 448-456.